Organizations contributing
to the program
Umeå University: Life science research in Umeå is versatile, interdisciplinary and of high scientific competence. The Coalition Umeå for Life Science (CU4LS) highlights the strengths and richness of Umeå Life Science research activities, spanning research areas from molecules to man, from microorganisms to ecosystems, theoretical approaches to experimental sciences, and into clinical research.
Arla Food: A global leader in improving premium nutrition. Together with our customers, research partners, suppliers, NGOs and others, we discover and deliver documented ingredients and products that can advance lifelong nutrition for the benefit of consumers around the world.
Chiesi Farmaceutici: Develops and distributes pharmaceuticals in over 100 countries and has 30 international companies in Europe, America, Asia and Africa.Today, Chiesi is one of the world's leading pharmaceutical companies in the respiratory field. Chiesi allocates roughly 20 percent of its turnover to research and development to find new medicines and treatments. The number of Research & Development programs continues to increase and diversify, enriching the therapeutic offer, focusing on three main business areas: AIR (respiratory diseases), RARE (rare and ultra-rare diseases) and CARE (Neonatology, Special Care and Consumer Healthcare).
Cropcision: Offers a step-change enhancement in fertilizer efficiency. We have developed a microplastic-free, control-release platform technology that, for the first time, makes precision placement of fertilizer granules and other active ingredients possible.
Industrial Doctoral School for Research and Innovation: Creates opportunities for collaboration between Umeå University researchers, business and the public sector through jointly funded research projects.
Nordic Biomarker: A Swedish original manufacturer of advanced reagents, calibrators and controls for coagulation and clinical chemistry analyzers. Offers products used for a wide range of routine and specialty tests. Our expertise covers all relevant technology areas, and we pride ourselves on being experts when it comes to both immunological, chromogenic as well as clotting assays.
Sartorius: Empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine. We offer technologies, platforms and partnerships for a common goal: better health for more people.
The CellFit Project: A collaboration led by Oslo University Hospital, Department of Cellular Therapy. The project includes project partners Oslo Cancer Cluster, SINTEF, and Thermo Fisher Scientific. Established in 2021, and funded by The Research Council of Norway, the Cellfit Project seeks to address one of the biggest challenges for cell-based cancer therapy – efficient and scalable production. The CellFit Project seeks to provide significantly improved cellular products (more active and in vivo persistent) and processes (higher yields, more streamlined).
University of Oxford: Ranked number 1 in the Times Higher Education (THE) World University Rankings for the ninth year running, and at the heart of this success is our ground-breaking research and innovation.
The Research Excellence Framework (REF) 2021 results show Oxford’s submission had the highest volume of world-leading research. The University of Oxford made the largest submission of any Higher Education Institution (HEI) in the UK, submitting over 3,600 researchers (3,405 full-time equivalent) into 29 subject areas, over 8,500 research outputs in a range of formats from journal articles to compositions, and 220 case studies about the impact of Oxford research beyond academia.
Umeå Municipality: Life science is a priority growth target for Umeå Municipality, strategically encouraging life science companies to establish themselves in the region.
Non-stage participating companies/organizations (updated continuously)
Agrisera: Provides off-the-shelf antibodies for plant and algal research, with prompt delivery worldwide, and reactivity to thousands of species.
Apoteket Produktion & Laboratorier (APL): One of Europe's leading companies in the development, analysis, and manufacture of extemporaneous and bearing preparations, as well as an established contract manufacturer in the Life Science industry.
BRIDGE Sweden: Building a platform to link expertise and research infrastructures in Sweden to advance biological product development.
Diamyd Medical: Develops precision medicine therapies for the prevention and treatment of autoimmune diabetes. A facility for manufacturing of biological products is being set up in Umeå with the primary purpose of manufacturing recombinant GAD65.
FOI: The Swedish Defence Research Agency, is one of Europe’s leading research institutes in defence and security. FOI is a government agency under the Ministry of Defence, and most of its activities are assignment-based
Lipigon: Develops new treatments for diseases caused by disruptions in the body's handling of fats – known as lipid-related diseases. The company's foundation is built upon over 50 years of research at Umeå University.
Lipum: Lipum AB (publ) is a clinical phase biopharmaceutical company specializing in the discovery and development of new treatments for chronic inflammatory diseases.
Medicvent: The mission is to develop, manufacture and promote a comprehensive range of products for the evacuation of air pollution mainly within the hospital care environment.
NorthX Biologics: A Swedish biopharma CDMO with expertise in a comprehensive spectrum of biologics, including recombinant proteins, virus products, extracellular vesicles, and an array of other advanced therapeutic entities.
Pharmaceutical Development Solna and OT Chemistry Uppsala: Parts of a new, Europe-based CDMO (name and brand to be revealed soon!) that provide Pharmaceutical Development Services for early pre-clinical, to late clinical stages. Medicinal Chemistry, API synthesis, Formulation-, Process- and Analytical development. Non-GMP, GLP and GMP manufacturing.
QureTech Bio: Develops new synthetic antibacterial agents that address significant medical need in infectious disease.
SpinChem: SpinChem provide technology solutions that reshape the way chemical process work is performed.
Testa Center: An initiative between the Swedish government and Cytiva. The main objective is to bridge the gap from discovery to industrialization.
UmanDiagnostics: Committed to deliver fast and accurate diagnosis of neurological diseases. The company develops and markets valuable tools for early detection of disease.
Vakona: Is developing a new, antibiotic-free treatment for inflammatory acne.
